Category: Official Press Release

AKEEYO presentará las cámaras AKY-NV-X2 y AKY-730 Pro en CES 2026 de Las Vegas

SHENZHEN, China, 25 de diciembre de 2025 /PRNewswire/ — AKEEYO eleva la inteligencia del vehículo en CES 2026 con dos sistemas de cámara revolucionarios. La cámara de salpicadero AKY-NV-X2 de 11 pulgadas con espejo retrovisor es ideal para conductores de automóviles, mientras que la cámara de acción AKY-730 Pro ofrece protección profesional para motociclistas y… Continue reading AKEEYO presentará las cámaras AKY-NV-X2 y AKY-730 Pro en CES 2026 de Las Vegas

AKEEYO présentera l’AKY-NV-X2 et l’AKY-730 Pro au salon CES 2026 à Las Vegas

SHENZHEN, Chine, 25 déc. 2025 /PRNewswire/ — AKEEYO fait progresser l’intelligence des véhicules au CES 2026 avec deux systèmes de caméra révolutionnaires. La caméra de tableau de bord à miroir de 11 pouces de l’AKY-NV-X2 est destinée aux automobilistes, tandis que la caméra d’action AKY-730 Pro offre une protection de qualité professionnelle aux motards et… Continue reading AKEEYO présentera l’AKY-NV-X2 et l’AKY-730 Pro au salon CES 2026 à Las Vegas

China’s First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent’s TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval

TABOSUN® (ipilimumab N01 injection) has been approved in combination with TYVYT® (sintilimab injection) for the neoadjuvant treatment of patients with stage IIB-III resectable microsatellite instability-high or mismatch repair deficient (MSI-H/dMMR) colon cancer. The TABOSUN® and TYVYT® combination therapy significantly improved pathological complete response (pCR) rates and enabled most patients to avoid the burden of postoperative adjuvant… Continue reading China’s First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent’s TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval

Thailand welcomes 2026 with countdown celebrations anchored by Phayao and Su-ngai Kolok

Tourism Authority of Thailand spotlights two flagship regional events alongside celebrations across Bangkok and key provincial destinations to mark the New Year BANGKOK, Dec. 25, 2025 /PRNewswire/ — Thailand is welcoming the arrival of 2026 with a nationwide programme of countdown celebrations, anchored by two flagship events organised by the Tourism Authority of Thailand (TAT)… Continue reading Thailand welcomes 2026 with countdown celebrations anchored by Phayao and Su-ngai Kolok

transcosmos launches AI training and annotation services leveraging talent across Japan and ASEAN

With a Human-in-the-Loop model built on employees, gig workers, and technologies, transcosmos delivers specialized AI data annotation services in Chinese, Japanese, and Korean TOKYO, Dec. 25, 2025 /PRNewswire/ — transcosmos today announced the release of highly specialized AI training and data annotation services in Chinese, Japanese, and Korean languages. The service covers both specialized and… Continue reading transcosmos launches AI training and annotation services leveraging talent across Japan and ASEAN

SM Investments certified as a Great Place to Work® in 2025

PASAY CITY, Philippines, Dec. 24, 2025 /PRNewswire/ — SM Investments Corporation (SM Investments), the parent company of the SM group, has been certified as a Great Place to Work for 2025 by the global authority on workplace culture, Great Place to Work®.  This certification is anchored on the Trust Index Survey, wherein SM employees affirmed long-term… Continue reading SM Investments certified as a Great Place to Work® in 2025

BC.GAME goes double-track: partnering with Abu Dhabi T10 and Deccan Gladiators to deliver a digital-first cricket spectacle

BELIZE CITY, Belize, Dec. 24, 2025 /PRNewswire/ — At the 2025 Abu Dhabi T10 League, BC.GAME took a “double-track” approach to modern sports sponsorship. Alongside league-level partnership visibility, the brand also teamed up with three-time champions Deccan Gladiators—bringing BC.GAME into the heart of the team‘s story and fan engagement. This year‘s Abu Dhabi T10 ran… Continue reading BC.GAME goes double-track: partnering with Abu Dhabi T10 and Deccan Gladiators to deliver a digital-first cricket spectacle

Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management (CBL-0201WR Phase 2). The study will evaluate CBL-514 in combination with Zepbound® (Eli Lilly) in subjects with obesity or overweight. Efficacy endpoints include changes in abdominal… Continue reading Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies

World NM: Volvo Will Stop Making Wagons for the American Market in April 2026001960

Volvo and wagons go a long way back. It all started with the Duett in 1953, whose name represents a dual-purpose vehicle that is good for both work and quality time with the family. But in recent years, increasing demand for sport utility vehicles saw Volvo slowly yet steadily trim down its long-roofed offerings. Over… Continue reading World NM: Volvo Will Stop Making Wagons for the American Market in April 2026001960